Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.03p
   
  • Change Today:
      0.025p
  • 52 Week High: 12.50
  • 52 Week Low: 1.98
  • Currency: UK Pounds
  • Shares Issued: 782.06m
  • Volume: 632,383
  • Market Cap: £15.84m

Shield Therapeutics shares leap as FDA approves Feraccru

By Duncan Ferris

Date: Friday 26 Jul 2019

LONDON (ShareCast) - (Sharecast News) - Shield Therapeutics shares soared on Friday after its Feraccru/Accrufer lead product received approval from the US Food and Drug Administration.
The drug, which is used to treat iron deficiency in adults, has already gained approval in Europe where it is sold under the name Feraccru, but will be marketed as Accrufer in the US.

The AIM-traded company said that market research suggests the prescription market for iron replacement therapy in the US is worth more than $1.0bn per year as between 8m and 9m people there suffer from iron deficiency anaemia. Management estimated that as many as two to three times this number require some sort of treatment for iron deficiency.

Shield Therapeutics said it is currently engaged in discussions with a number of unnamed third parties regarding the commercialisation of Accrufer in the US.

Carl Sterritt, chief executive of Shield Therapeutics, said: "We are delighted that the FDA has approved the new drug application for our lead asset. This is a further major milestone for the company which we have worked tirelessly to achieve, and I am very proud to lead the team within Shield that has made this happen. With this broad approval and IP protection out to 2035, Feraccru/Accrufer has a real and very attractive long-term market opportunity to exploit in the USA."

Shield Therapeutics' shares were up 67.26% at 173.11p at 1318 BST.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

STX Market Data

Currency UK Pounds
Share Price 2.03p
Change Today 0.025p
% Change 1.25 %
52 Week High 12.50
52 Week Low 1.98
Volume 632,383
Shares Issued 782.06m
Market Cap £15.84m

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
48.28% below the market average48.28% below the market average48.28% below the market average48.28% below the market average48.28% below the market average
37.04% above the sector average37.04% above the sector average37.04% above the sector average37.04% above the sector average37.04% above the sector average
Price Trend
94.74% below the market average94.74% below the market average94.74% below the market average94.74% below the market average94.74% below the market average
89.47% below the sector average89.47% below the sector average89.47% below the sector average89.47% below the sector average89.47% below the sector average
Income Not Available
Growth
57.48% above the market average57.48% above the market average57.48% above the market average57.48% above the market average57.48% above the market average
72.97% above the sector average72.97% above the sector average72.97% above the sector average72.97% above the sector average72.97% above the sector average

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 28-Mar-2024

Time Volume / Share Price
16:22 4,500 @ 2.05p
15:40 200 @ 2.05p
15:40 487 @ 2.05p
15:36 30,000 @ 2.03p
15:33 4,357 @ 1.99p

Top of Page